Loading...
Axitinib, cabozantinib, everolimus, nivolumab, sunitinib and best supportive care in previously treated renal cell carcinoma: a systematic review and economic evaluation.
BACKGROUND: Several therapies have recently been approved for use in the NHS for pretreated advanced or metastatic renal cell carcinoma (amRCC), but there is a lack of comparative evidence to guide decisions between them. OBJECTIVE: To evaluate the clinical effectiveness and cost-effectiveness of ax...
Na minha lista:
| Udgivet i: | Health Technol Assess |
|---|---|
| Main Authors: | , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
NIHR Journals Library
2018
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5817410/ https://ncbi.nlm.nih.gov/pubmed/29393024 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3310/hta22060 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|